Seeing Is Believing

Currently out of the existing stock ratings of Balaji Prasad, 20 are a SELL (9.52%), 29 are a HOLD (13.81%), 161 are a BUY (76.67%).
Analyst Balaji Prasad, carries an average stock price target met ratio of 57.02% that have a potential upside of 27.92% achieved within 340 days. Previously, Balaji Prasad worked at BARCLAYS.
Balaji Prasad’s has documented 421 price targets and ratings displayed on 28 stocks. The coverage was on Healthcare, Energy sectors.
Most recent stock forecast was given on EOLS, Evolus at 05-Mar-2025.
Analyst best performing recommendations are on ENDP (ENDO INTERNATIONAL PLC).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $123.52 was fulfilled within 1 day with a profit of $11.16 (9.93%) receiving and performance score of 99.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 10-Aug-2022
$9
$3.31 (58.17%)
$10
5 months 5 days ago
(27-Apr-2026)
12/26 (46.15%)
$3.42 (61.29%)
247
Hold Since 25-Feb-2026
$7
$1.31 (23.02%)
$7
6 months 1 days ago
(31-Mar-2026)
4/8 (50%)
$1.6 (29.63%)
134
Hold Since 25-Jul-2024
$8
$2.31 (40.60%)
$7
8 months 25 days ago
(07-Jan-2026)
1/2 (50%)
$0.1 (1.27%)
53
Hold Since 10-Jul-2024
$8
$2.31 (40.60%)
1 years 4 months 27 days ago
(05-May-2025)
2/2 (100%)
$3.07 (62.27%)
86
Hold Since 22-Jan-2021
$3
$-2.69 (-47.28%)
$9
2 years 2 months ago
(02-Aug-2024)
12/15 (80%)
$-2.63 (-46.71%)
185